{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,4]],"date-time":"2026-11-04T23:25:57Z","timestamp":1793834757512,"version":"4.6.1"},"reference-count":33,"publisher":"Springer Science and Business Media LLC","issue":"11","license":[{"start":{"date-parts":[[2026,8,31]],"date-time":"2026-08-31T00:00:00Z","timestamp":1788134400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,8,31]],"date-time":"2026-08-31T00:00:00Z","timestamp":1788134400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Hypertens Res"],"published-print":{"date-parts":[[2026,11]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Co-occurring obesity and hypertension is associated with high cardiovascular risk, whereas the prognostic significance of underweight in the presence of hypertension remains uncertain. We examined whether the association between body mass index category and 10-year risk of major adverse cardiovascular events differed across blood pressure categories. Using the Japan Medical Claims Database from 2005 to 2023, we analyzed 6,262,298 adults without prior cardiovascular disease, chronic renal failure, dialysis, or antihypertensive medication use at baseline. Blood pressure was classified as normal (&lt;120 and &lt;80\u2009mmHg), high-normal (120\u2013129 and &lt;80\u2009mmHg), elevated (130\u2013139 and\/or 80\u201389\u2009mmHg), stage 1 hypertension (140\u2013159 and\/or 90\u201399\u2009mmHg), or stage 2\/3 hypertension (\u2265160 and\/or \u2265100\u2009mmHg). Body mass index was classified as underweight (&lt;18.5\u2009kg\/m\u00b2), normal weight (18.5\u201324.9), overweight (25.0\u201329.9), or obesity (\u226530.0). The primary outcome was major adverse cardiovascular events within 10 years. Multivariable Cox proportional hazards models estimated hazard ratios for combined blood pressure and body mass index categories, using normal blood pressure with normal weight as the reference. During a median follow-up of 1,183 days, 34,034 participants experienced major adverse cardiovascular events. Underweight showed a marked blood pressure-dependent increase in risk, with the hazard ratio rising from 1.14 (95% confidence interval, 1.07\u20131.22) in normal blood pressure to 5.01 (4.23\u20135.93) in stage 2\/3 hypertension. The interaction between blood pressure category and body mass index category was significant. These findings suggest that higher blood pressure may amplify the adverse prognostic significance of underweight.<\/jats:p>","DOI":"10.1038\/s41440-026-02781-8","type":"journal-article","created":{"date-parts":[[2026,8,31]],"date-time":"2026-08-31T03:52:36Z","timestamp":1788148356000},"page":"2925-2935","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Body mass index modifies cardiovascular risk across blood pressure categories, particularly among underweight adults with hypertension: a 6.3 million\u2011person nationwide Japanese cohort study"],"prefix":"10.1038","volume":"49","author":[{"given":"Takahisa","family":"Kawano","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tomohisa","family":"Seki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hiroaki","family":"Araie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Akiko","family":"Matsunaga","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Naohiro","family":"Konoshita","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Osamu","family":"Yamamura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masamichi","family":"Ikawa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,8,31]]},"reference":[{"key":"2781_CR1","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1038\/s41581-019-0244-2","volume":"16","author":"KT Mills","year":"2020","unstructured":"Mills KT, Stefanescu A, He J. The global epidemiology of hypertension. Nat Rev Nephrol. 2020;16:223\u201337. https:\/\/doi.org\/10.1038\/s41581-019-0244-2.","journal-title":"Nat Rev Nephrol"},{"key":"2781_CR2","doi-asserted-by":"publisher","first-page":"1223","DOI":"10.1016\/S0140-6736(20)30752-2","volume":"396","author":"C Abbafati","year":"2020","unstructured":"Abbafati C. Global burden of 87 risk factors in 204 countries and territories, 1990\u20132019: a systematic analysis for the Global Burden of Disease Study 2019. Lancet. 2020;396:1223\u201349. https:\/\/doi.org\/10.1016\/S0140-6736(20)30752-2.","journal-title":"Lancet"},{"key":"2781_CR3","doi-asserted-by":"publisher","DOI":"10.1186\/s12916-023-02925-4","volume":"21","author":"J Sun","year":"2023","unstructured":"Sun J, Qiao Y, Zhao M, Magnussen CG, Xi B. Global, regional, and national burden of cardiovascular diseases in youths and young adults aged 15\u201339 years in 204 countries\/territories, 1990\u20132019: a systematic analysis of Global Burden of Disease Study 2019. BMC Med. 2023;21:222. https:\/\/doi.org\/10.1186\/s12916-023-02925-4.","journal-title":"BMC Med"},{"key":"2781_CR4","doi-asserted-by":"publisher","first-page":"275","DOI":"10.1001\/jama.2009.2025","volume":"303","author":"JM Gaziano","year":"2010","unstructured":"Gaziano JM. Fifth phase of the epidemiologic transition: The age of obesity and inactivity. JAMA. 2010;303:275\u20136. https:\/\/doi.org\/10.1001\/jama.2009.2025.","journal-title":"JAMA"},{"key":"2781_CR5","doi-asserted-by":"publisher","first-page":"654","DOI":"10.1161\/01.HYP.0000184282.51550.00","volume":"46","author":"F Thomas","year":"2005","unstructured":"Thomas F, Bean K, Pannier B, Oppert JM, Guize L, Benetos A. Cardiovascular mortality in overweight subjects: The key role of associated risk factors. Hypertension. 2005;46:654\u20139. https:\/\/doi.org\/10.1161\/01.HYP.0000184282.51550.00.","journal-title":"Hypertension"},{"key":"2781_CR6","doi-asserted-by":"publisher","first-page":"8769","DOI":"10.1097\/MD.0000000000008769","volume":"96","author":"D Park","year":"2017","unstructured":"Park D, Lee JH, Han S. Underweight: Another risk factor for cardiovascular disease?. Medicine. 2017;96:8769 https:\/\/doi.org\/10.1097\/MD.0000000000008769.","journal-title":"Medicine"},{"key":"2781_CR7","doi-asserted-by":"publisher","first-page":"970","DOI":"10.1016\/S0140-6736(13)61836-X","volume":"383","author":"Y Lu","year":"2014","unstructured":"Lu Y, Hajifathalian K, Ezzati M, Woodward M, Rimm EB, et al. Metabolic mediators of the effects of body-mass index, overweight, and obesity on coronary heart disease and stroke: A pooled analysis of 97 prospective cohorts with 1\u00b78 million participants. Global Burden of etabolic Risk Factors for Chronic Diseases Collaboration (BI Mediated Effects). Lancet. 2014;383:970\u201383. https:\/\/doi.org\/10.1016\/S0140-6736(13)61836-X.","journal-title":"Lancet"},{"key":"2781_CR8","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1038\/s41440-025-02462-y","volume":"49","author":"Y Ohya","year":"2026","unstructured":"Ohya Y. The Japanese Society of Hypertension Guidelines for the management of elevated blood pressure and hypertension 2025 (JSH2025). Hypertens Res. 2026;49:9\u2013235. https:\/\/doi.org\/10.1038\/s41440-025-02462-y.","journal-title":"Hypertens Res"},{"key":"2781_CR9","doi-asserted-by":"publisher","first-page":"118","DOI":"10.1002\/jgf2.422","volume":"22","author":"K Nagai","year":"2021","unstructured":"Nagai K, Tanaka T, Kodaira N, Kimura S, Takahashi Y, Nakayama T. Data resource profile: JMDC claims database sourced from health insurance societies. J Gen Fam Med. 2021;22:118\u201327. https:\/\/doi.org\/10.1002\/jgf2.422.","journal-title":"J Gen Fam Med"},{"key":"2781_CR10","doi-asserted-by":"publisher","first-page":"3099","DOI":"10.1038\/s41440-024-01875-5","volume":"47","author":"M Satoh","year":"2024","unstructured":"Satoh M, Nakayama S, Toyama M, Hashimoto H, Murakami T, Metoki H. Usefulness and caveats of real-world data for research on hypertension and its association with cardiovascular or renal disease in Japan. Hypertens Res. 2024;47:3099\u2013113. https:\/\/doi.org\/10.1038\/s41440-024-01875-5.","journal-title":"Hypertens Res"},{"key":"2781_CR11","doi-asserted-by":"publisher","first-page":"367","DOI":"10.5551\/jat.rv22047","volume":"33","author":"A Hirata","year":"2026","unstructured":"Hirata A, Uchida T. The specific health checkups and specific health guidance program: a strategy for the prevention of cardiovascular disease in Japan. J Atheroscler Thromb. 2026;33:367\u201376. https:\/\/doi.org\/10.5551\/jat.rv22047.","journal-title":"J Atheroscler Thromb"},{"key":"2781_CR12","doi-asserted-by":"publisher","first-page":"301","DOI":"10.5551\/jat.12.301","volume":"12","author":"Y Matsuzawa","year":"2005","unstructured":"Matsuzawa Y. Metabolic syndrome-definition and diagnostic criteria in Japan. J Atheroscler Thromb. 2005;12:301 https:\/\/doi.org\/10.5551\/jat.12.301.","journal-title":"J Atheroscler Thromb"},{"key":"2781_CR13","doi-asserted-by":"publisher","first-page":"1242845","DOI":"10.3389\/fcvm.2023.1242845","volume":"10","author":"A Volkova","year":"2023","unstructured":"Volkova A, Shulgin B, Helmlinger G, Peskov K, Sokolov V. Optimization of the MACE endpoint composition to increase power in studies of lipid-lowering therapies\u2014a model-based meta-analysis. Front Cardiovasc Med. 2023;10:1242845 https:\/\/doi.org\/10.3389\/fcvm.2023.1242845.","journal-title":"Front Cardiovasc Med"},{"key":"2781_CR14","doi-asserted-by":"publisher","first-page":"367","DOI":"10.2147\/CLEP.S245555","volume":"12","author":"Y Ono","year":"2020","unstructured":"Ono Y, Taneda Y, Takeshima T, Iwasaki K, Yasui A. Validity of Claims diagnosis codes for cardiovascular diseases in diabetes patients in Japanese administrative database. Clin Epidemiol. 2020;12:367\u201375. https:\/\/doi.org\/10.2147\/CLEP.S245555.","journal-title":"Clin Epidemiol"},{"key":"2781_CR15","doi-asserted-by":"publisher","DOI":"10.1186\/s12913-018-3727-0","volume":"18","author":"T Ando","year":"2018","unstructured":"Ando T, Ooba N, Mochizuki M, Koide D, Kimura K, Lee SL, et al. Positive predictive value of ICD-10 codes for acute myocardial infarction in Japan: A validation study at a single center. BMC Health Serv Res. 2018;18:895. https:\/\/doi.org\/10.1186\/s12913-018-3727-0.","journal-title":"BMC Health Serv Res"},{"key":"2781_CR16","doi-asserted-by":"publisher","first-page":"476","DOI":"10.1016\/j.je.2016.09.009","volume":"27","author":"H Yamana","year":"2017","unstructured":"Yamana H, Moriwaki M, Horiguchi H, Kodan M, Fushimi K, Yasunaga H. Validity of diagnoses, procedures, and laboratory data in Japanese administrative data. J Epidemiol. 2017;27:476\u201382. https:\/\/doi.org\/10.1016\/j.je.2016.09.009.","journal-title":"J Epidemiol"},{"key":"2781_CR17","doi-asserted-by":"publisher","first-page":"646","DOI":"10.1111\/jch.14151","volume":"23","author":"D Shima","year":"2021","unstructured":"Shima D, Ii Y, Higa S, Kohro T, Hoshide S, Kono K, et al. Validation of novel identification algorithms for major adverse cardiovascular events in a Japanese claims database. J Clin Hypertens. 2021;23:646\u201355. https:\/\/doi.org\/10.1111\/jch.14151.","journal-title":"J Clin Hypertens"},{"key":"2781_CR18","doi-asserted-by":"publisher","first-page":"66116","DOI":"10.1371\/journal.pone.0066116","volume":"8","author":"N Ooba","year":"2013","unstructured":"Ooba N, Setoguchi S, Ando T, Sato T, Yamaguchi T, Mochizuki M, et al. Claims-based definition of death in Japanese Claims Database: Validity and Implications. PLoS One. 2013;8:66116 https:\/\/doi.org\/10.1371\/journal.pone.0066116.","journal-title":"PLoS One"},{"key":"2781_CR19","doi-asserted-by":"publisher","first-page":"2244","DOI":"10.1161\/CIRCULATIONAHA.120.052624","volume":"143","author":"H Kaneko","year":"2021","unstructured":"Kaneko H, Yano Y, Itoh H, Morita K, Kiriyama H, Kamon T, et al. Association of Blood Pressure Classification Using the 2017 American College of Cardiology\/ American Heart Association Blood Pressure Guideline with Risk of Heart Failure and Atrial Fibrillation. Circulation. 2021;143:2244\u201353. https:\/\/doi.org\/10.1161\/CIRCULATIONAHA.120.052624.","journal-title":"Circulation"},{"key":"2781_CR20","doi-asserted-by":"publisher","first-page":"863","DOI":"10.1177\/1536867x1401400410","volume":"14","author":"KM Aloisio","year":"2014","unstructured":"Aloisio KM, Swanson SA, Micali N, Field A, Horton NJ. Analysis of partially observed clustered data using generalized estimating equations and multiple imputation. Stata J. 2014;14:863\u201383. https:\/\/doi.org\/10.1177\/1536867x1401400410.","journal-title":"Stata J"},{"key":"2781_CR21","unstructured":"Obesity: preventing and managing the global epidemic. Report of a WHO consultation. World Health Organ Tech Rep Ser. 2000;894."},{"key":"2781_CR22","doi-asserted-by":"publisher","unstructured":"Rubin DB, Schenker N. Multiple imputation in health-care databases: An overview and some applications. Stat Med. 1991;10. https:\/\/doi.org\/10.1002\/sim.4780100410","DOI":"10.1002\/sim.4780100410"},{"key":"2781_CR23","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1177\/1479164111422828","volume":"9","author":"K Suastika","year":"2012","unstructured":"Suastika K, Dwipayana P, Saraswati MR, Gotera W, Budhiarta AA, Sutanegara ND, et al. Underweight is an important risk factor for coronary heart disease in the population of Ceningan Island, Bali. Diab Vasc Dis Res. 2012;9:75\u20137. https:\/\/doi.org\/10.1177\/1479164111422828.","journal-title":"Diab Vasc Dis Res"},{"key":"2781_CR24","doi-asserted-by":"publisher","unstructured":"Huang Y, Peng J, Wang W, Zheng X, Qin G, Xu H. Age-dependent association between Body Mass Index and all-cause mortality among patients with hypertension: a longitudinal population-based cohort study in China. Clin Epidemiol. 2023;15. https:\/\/doi.org\/10.2147\/CLEP.S442162","DOI":"10.2147\/CLEP.S442162"},{"key":"2781_CR25","doi-asserted-by":"publisher","unstructured":"Liu M, Zhang Z, Zhou C, Ye Z, He P, Zhang Y, et al. Predicted fat mass and lean mass in relation to all-cause and cause-specific mortality. J Cachexia Sarcopenia Muscle. 2022;13. https:\/\/doi.org\/10.1002\/jcsm.12921","DOI":"10.1002\/jcsm.12921"},{"key":"2781_CR26","doi-asserted-by":"publisher","first-page":"457","DOI":"10.2188\/jea.JE20180124","volume":"29","author":"A Hozawa","year":"2019","unstructured":"Hozawa A, Hirata T, Yatsuya H, Murakami Y, Kuriyama S, Tsuji I, et al. Association between body mass index and all-cause death in Japanese population: Pooled individual participant data analysis of 13 cohort studies. J Epidemiol. 2019;29:457\u201363. https:\/\/doi.org\/10.2188\/jea.JE20180124.","journal-title":"J Epidemiol"},{"key":"2781_CR27","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-025-67268-5","volume":"17","author":"JJ Noubiap","year":"2026","unstructured":"Noubiap JJ, Nansseu JR, Nyaga UF, Ndoadoumgue AL, Ngouo AT, Tounouga DN, et al. Worldwide trends in metabolic syndrome from 2000 to 2023: a systematic review and modelling analysis. Nat Commun. 2026;17:573. https:\/\/doi.org\/10.1038\/s41467-025-67268-5.","journal-title":"Nat Commun"},{"key":"2781_CR28","doi-asserted-by":"publisher","unstructured":"Taylor LE, Sullivan JC. Sex differences in obesity-induced hypertension and vascular dysfunction: A protective role for estrogen in adipose tissue inflammation? Am J Physiol Regul Integr Comp Physiol. 2016;311. https:\/\/doi.org\/10.1152\/ajpregu.00202.2016","DOI":"10.1152\/ajpregu.00202.2016"},{"key":"2781_CR29","doi-asserted-by":"publisher","unstructured":"Leszczak J, Czenczek-Lewandowska E, Asif M, Baran J, Mazur A, Wyszy\u0144ska J. Risk factors and prevalence of hypertension in older adults from south-eastern Poland: an observational study. Sci Rep. 2024;14. https:\/\/doi.org\/10.1038\/s41598-024-52009-3","DOI":"10.1038\/s41598-024-52009-3"},{"key":"2781_CR30","doi-asserted-by":"publisher","first-page":"683","DOI":"10.1136\/heartjnl-2021-320278","volume":"108","author":"W Li","year":"2022","unstructured":"Li W, Fang W, Huang Z, Wang X, Cai Z, Chen G, et al. Association between age at onset of overweight and risk of hypertension across adulthood. Heart. 2022;108:683\u20138. https:\/\/doi.org\/10.1136\/heartjnl-2021-320278.","journal-title":"Heart"},{"key":"2781_CR31","doi-asserted-by":"publisher","unstructured":"Flegal KM, Kit BK, Orpana H, Graubard BI. Association of all-cause mortality with overweight and obesity using standard body mass index categories a systematic review and meta-analysis. JAMA. 2013;309. https:\/\/doi.org\/10.1001\/jama.2012.113905","DOI":"10.1001\/jama.2012.113905"},{"key":"2781_CR32","doi-asserted-by":"publisher","first-page":"447","DOI":"10.1097\/HCO.0000000000001069","volume":"38","author":"MI Barillas-Lara","year":"2023","unstructured":"Barillas-Lara MI, Faaborg-Andersen CC, Quintana RA, Loro-Ferrer JF, Mandras SA, Dasilva-Deabreu A. Clinical considerations and pathophysiological associations among obesity, weight loss, heart failure, and hypertension. Curr Opin Cardiol. 2023;38:447\u201355. https:\/\/doi.org\/10.1097\/HCO.0000000000001069.","journal-title":"Curr Opin Cardiol"},{"key":"2781_CR33","doi-asserted-by":"publisher","first-page":"e38","DOI":"10.1161\/HYP.0000000000000202","volume":"78","author":"ME Hall","year":"2021","unstructured":"Hall ME, Cohen JB, Ard JD, Egan BM, Hall JE, Lavie CJ, et al. Weight-Loss Strategies for Prevention and Treatment of Hypertension: A Scientific Statement from the American Heart Association. Hypertension. 2021;78:e38\u2013e50. https:\/\/doi.org\/10.1161\/HYP.0000000000000202.","journal-title":"Hypertension"}],"container-title":["Hypertension Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41440-026-02781-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41440-026-02781-8","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41440-026-02781-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,11,4]],"date-time":"2026-11-04T23:03:30Z","timestamp":1793833410000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41440-026-02781-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8,31]]},"references-count":33,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2026,11]]}},"alternative-id":["2781"],"URL":"https:\/\/doi.org\/10.1038\/s41440-026-02781-8","relation":{},"ISSN":["0916-9636","1348-4214"],"issn-type":[{"value":"0916-9636","type":"print"},{"value":"1348-4214","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,8,31]]},"assertion":[{"value":"22 September 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 July 2026","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 August 2026","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"31 August 2026","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","label":"Conflict of interest","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}}]}}